PRESS RELEASE No. 064/KFCP-DIR/PR/IX/22
Jakarta, September 19th, 2022 – PT Kalbe Farma Tbk or Kalbe, through its subsidiary KlikDokter, has signed a Memorandum of Understanding (MoU) with GI VITA, a technology company for health datas. This collaboration in the digital health service business is aiming for the Indonesian market.
“KlikDokter will increase its service quality through an AI solution by GI Vita, which will be the basis of service expansion through lifelog datas,” as stated by the CEO of KlikDokter, Hendra Tjong.
Kilyeon Lee, the CEO of GI VITA, also agreed with Hendra Tjong, stating that the collaboration would maximize the function of the smart device and the development of algorhytm for lifelog datas.
According to Kilyeon Lee, “This partnership is significant because of the recognitio of expertise in the connection between smart devices and the development of algorhytm for lifelog datas. Therefore, we will accelarate the development of markets abroad.”
GI VITA has perfected KlikDokter with the AI solution to gather lifelog datas by using smart watches and scales, as well as analyzing gathered datas from devices and applications.
GI VITA also believed on the possibility of lifelog datas for telemedicine through KlikDokter. Furthermore, this collaboration with Kalbe Farma Group will provide an opportunity to enter the markets of Southeast Asian and Indonesia.
KlikDokter is a digital health platform in Indonesia and is a subsidiary of PT Kalbe Farma Tbk. Since its foundation, KlikDokter upholds the spirit of CIE (Communication, Information, and Education), with the purpose of improving the health of all Indonesian people.
KlikDokter provides health information that emphasizes on accuracy and updates from reliable sources. It also has several features of health services, including 24-hour online consultations, health tools, hospital directories, online medication recommendations, medication deliveries, a booking online real time feature, and other health features, which can be accessed in both its website and application.
On the other hand, GI VITA is a company that provides an AI-based health application called Rothy, which can assist the users in managing their own health independently. Rothy can gather and manage real time lifelog datas. It also provides an AI-based Healthy Living Guideline developed by data professionals.
Kalbe at a Glance
Founded in 1966, PT Kalbe Farma Tbk (Kalbe) is one of the largest open pharmaceutical companies in Southeast Asia. The company has four main divisions that engage in a portfolio of reliable and diversed brands, such as the prescription medicine division, the health product division which handles free medicines, multivitamins, and ready-to-drink supplement beverages, and the distribution and logistics divisions.
Kalbe has also developed a digital service ecosystem for the society, both in B2B with EMOS and in B2C with KlikDokter. EMOS is an order management application system that facilitates the distribution channels in commencing stock management or supply chain, while KlikDokter is a digital platform for health services, specifically telemedicine, which provides necessary health consultations and products for the society.
Now, Kalbe has more than 40 subsidiaries and 15 production facilities with international standards, employing around 16.000 employees who are being stationed in 76 branches all around Indonesia. Kalbe’s shares has been recorded in the Indonesia Stock Exchange (IDX) since 1991 (IDX:KLBF).